Assessment of Serum level of Apolipoprotein E4 in Patients with Vitiligo: A Comparative Review DOI Open Access

Essam Aql,

Omnia Babekir Abdallah,

Ghada Abdel Khalik

et al.

Benha Journal of Applied Sciences, Journal Year: 2023, Volume and Issue: 8(8), P. 29 - 37

Published: Aug. 29, 2023

Background: Vitiligo is an acquired autoimmune disorder characterized by patchy depigmentation in the skin and hair.Dysregulation of lipid metabolism immune dysregulation are key factors pathogenesis vitiligo.Apolipoprotein E4 (ApoE4), a protein involved metabolism, has been implicated various health conditions.Assessing serum levels ApoE4 patients with vitiligo may provide insights into disease process clinical implications.Objective: The review aims to explore potential role pathogenesis, its association dysregulation, implications altered levels.Conclusions: In conclusion, assessment Apolipoprotein (ApoE4) holds promise as avenue for understanding implications.

Language: Английский

A Paradigm Shift on Emergence of Pharmacogenomics in the Era of Personalized Medicine DOI
Neha Kukreti,

Khushi Lamba,

Pankaj Pant

et al.

Advances in medical technologies and clinical practice book series, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 34

Published: Dec. 13, 2024

Pharmacogenomics is the study of genetic modifications in patients that influence their potential to metabolize medications, encouraging tolerability and desired effect. Genetic (like genome-wide association & candidate gene) methods may help choosing most suitable drug dosage, by impeding adverse reactions (ADRs). are usually documented as key steps personalized medicine. The significance medicine healthcare developing due its defined molecular basis. Personalized anticipates beneficial or serious side effects a medication using specific individual's profile. In recent year's pharmacogenomics approaches being widely used personalizing therapies for diseases like Cancer, Rheumatoid arthritis, Asthma, Type-1 diabetes many psychiatric disorders (depression, psychosis, schizophrenia etc.).This chapter provides an overview present importance identifies challenges need be conquered effective

Language: Английский

Citations

0

The QPLEX™ Plus Assay Kit for the Early Clinical Diagnosis of Alzheimer’s Disease DOI Open Access
Hunjong Na, Ki Young Shin, Dokyung Lee

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(13), P. 11119 - 11119

Published: July 5, 2023

We recently developed a multiplex diagnostic kit, QPLEX™ Alz plus assay which captures amyloid-β1-40, galectin-3 binding protein, angiotensin-converting enzyme, and periostin simultaneously using microliters of peripheral blood utilizes an optimized algorithm for screening Alzheimer’s disease (AD) by correlating with cerebral amyloid deposition. Owing to the demand early AD detection, we investigate potential our kit clinical diagnosis AD. A total 1395 participants were recruited, their samples analyzed kit. The average values in each group increased gradually order progression continuum AD: cognitively normal (0.382 ± 0.150), subjective cognitive decline (0.452 0.130), mild impairment (0.484 0.129), (0.513 0.136). between showed statistically significant differences among groups divided Mini-Mental State Examination Clinical Dementia Rating. could be used distinguish or function. Because blood-based is more accessible, convenient, cost- time-effective than spinal fluid positron emission tomography imaging-based diagnosis, can potentially health checkups

Language: Английский

Citations

1

Assessment of Serum level of Apolipoprotein E4 in Patients with Vitiligo: A Comparative Review DOI Open Access

Essam Aql,

Omnia Babekir Abdallah,

Ghada Abdel Khalik

et al.

Benha Journal of Applied Sciences, Journal Year: 2023, Volume and Issue: 8(8), P. 29 - 37

Published: Aug. 29, 2023

Background: Vitiligo is an acquired autoimmune disorder characterized by patchy depigmentation in the skin and hair.Dysregulation of lipid metabolism immune dysregulation are key factors pathogenesis vitiligo.Apolipoprotein E4 (ApoE4), a protein involved metabolism, has been implicated various health conditions.Assessing serum levels ApoE4 patients with vitiligo may provide insights into disease process clinical implications.Objective: The review aims to explore potential role pathogenesis, its association dysregulation, implications altered levels.Conclusions: In conclusion, assessment Apolipoprotein (ApoE4) holds promise as avenue for understanding implications.

Language: Английский

Citations

0